Original Research
Published on 25 Apr 2022
in Cardiovascular Endocrinology
Original Research
Published on 22 Apr 2022
in Cardiovascular Endocrinology
Original Research
Published on 12 Apr 2022
in Cardiovascular Endocrinology
Original Research
Published on 18 Mar 2022
in Cardiovascular Endocrinology
Original Research
Published on 18 Mar 2022
in Cardiovascular Endocrinology
Original Research
Published on 17 Mar 2022
in Cardiovascular Endocrinology
Review
Published on 09 Mar 2022
in Cardiovascular Endocrinology
Systematic Review
Published on 07 Mar 2022
in Cardiovascular Endocrinology
Systematic Review
Published on 04 Mar 2022
in Cardiovascular Endocrinology
Original Research
Published on 22 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 22 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 21 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 15 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 09 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 08 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 07 Feb 2022
in Cardiovascular Endocrinology
Review
Published on 03 Feb 2022
in Cardiovascular Endocrinology
Original Research
Published on 25 Jan 2022
in Cardiovascular Endocrinology
Original Research
Published on 10 Jan 2022
in Cardiovascular Endocrinology
Original Research
Published on 14 Dec 2021
in Cardiovascular Endocrinology
Original Research
Published on 30 Nov 2021
in Cardiovascular Endocrinology
Review
Published on 12 Nov 2021
in Cardiovascular Endocrinology
Original Research
Published on 11 Nov 2021
in Cardiovascular Endocrinology
Original Research
Published on 05 Nov 2021
in Cardiovascular Endocrinology
![Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial](https://www.frontiersin.org/files/myhome article library/790405/790405_Thumb_400.jpg)
